Cargando…

New Prognostic and Predictive Markers in Cancer Progression

Detalles Bibliográficos
Autores principales:	Costantini, Susan, Budillon, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698401/ https://www.ncbi.nlm.nih.gov/pubmed/33212936 http://dx.doi.org/10.3390/ijms21228667

Ejemplares similares

Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer †
por: Costantini, Susan, et al.
Publicado: (2021)

New Prognostic and Predictive Markers in Head and Neck Tumors
por: Cantile, Monica, et al.
Publicado: (2016)

Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy
por: Budillon, Alfredo, et al.
Publicado: (2019)

Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer
por: Capone, Francesca, et al.
Publicado: (2020)

At last, a predictive and prognostic marker for radiotherapy?
por: Coates, Philip, et al.
Publicado: (2010)

Prognostic and predictive markers in glioblastoma and ALK overexpression
por: Kim, Jang-Hee
Publicado: (2021)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches
por: Leone, Alessandra, et al.
Publicado: (2017)

Prognostic marker and target in prostate cancer
por: Lavorgna, Giovanni, et al.
Publicado: (2015)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles
por: Ciardiello, Chiara, et al.
Publicado: (2018)

NAA10 as a New Prognostic Marker for Cancer Progression
por: Kim, Sun Myung, et al.
Publicado: (2020)

Frizzled-10 and cancer progression: Is it a new prognostic marker?
por: Scavo, Maria Principia, et al.
Publicado: (2017)

Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers
por: Polo, Andrea, et al.
Publicado: (2018)

Tissue transglutaminase: a new target to reverse cancer drug resistance
por: Budillon, Alfredo, et al.
Publicado: (2011)

Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019)

Reliable prognostic markers for the progression of heart failure in older adults: Is ambulatory blood pressure monitoring one of them?()
por: Coca, A.
Publicado: (2021)

New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
por: Costantini, Susan, et al.
Publicado: (2023)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line
por: Marchese, Silvia, et al.
Publicado: (2018)

Prognostic and Predictive Markers in Cancer
por: Conley, Barbara A., et al.
Publicado: (2004)

Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays
por: Capone, Francesca, et al.
Publicado: (2016)

Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023)

Predictive markers of endocrine response in breast cancer
por: Mosly, Duniya, et al.
Publicado: (2018)

An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer
por: Costantini, Susan, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020)

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Evaluating the Effects of an Organic Extract from the Mediterranean Sponge Geodia cydonium on Human Breast Cancer Cell Lines
por: Costantini, Susan, et al.
Publicado: (2017)

Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection
por: Costantini, Susan, et al.
Publicado: (2023)

New prognostic models in metastatic renal cancer
por: Lim, Louise, et al.
Publicado: (2012)

REporting recommendations for tumour MARKer prognostic studies (REMARK)
por: Harris, A L
Publicado: (2005)

Developmental Gene Markers in Tumor Pathogenesis and Progression
por: Cantile, Monica, et al.
Publicado: (2019)

Is Immature Granulocyte Count a Potential Prognostic Marker for Upper Gastrointestinal Tract Bleeding? A New Road to Explore
por: Prabu, Natesh R, et al.
Publicado: (2020)

Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer
por: Nunziata, Carmine, et al.
Publicado: (2019)

Environment and bladder cancer: molecular analysis by interaction networks
por: Polo, Andrea, et al.
Publicado: (2017)

On the prognostic & predictive impact of immune cells system in colorectal cancer
por: Grizzi, Fabio, et al.
Publicado: (2012)

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer
por: Kim, Hungdai
Publicado: (2012)

Prognostic Factors Research in Breast Cancer Patients: New Paths
por: Susini, Tommaso, et al.
Publicado: (2022)

New molecular aspects in pathogenesis and progression of pancreatic cancer
por: Büchler, Peter, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_r6dte956fflggh7vcgo039lrsi